Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- As insulin nears 10th decade of discovery, experts reflect
-
- Open adrenalectomy viable option in adrenocortical cancer
- If we use evidence-based medicine, why not evidence-based policy? Richard O. Dolinar, MD
- Third-party payers fail to respect the endocrinologist as a specialist David S.H. Bell, MB, FACE, FACP
- CASTLE: Cancer of the thyroid showing thymus-like differentiation Stephanie L. Lee, MD, PhD, ECNU
- Bardoxolone increased risk for CV events in patients with diabetes, CKD
- Bazedoxifene/conjugated estrogens yielded low endometrial hyperplasia rates, improved BMD
- Consumption of sugar-sweetened beverages increased endometrial cancer risk
- EURODIAB: High, low HbA1c levels increased risk for all-cause mortality
-
- Exercise training modestly improved insulin levels of children, adolescents
- High levels of serum testosterone weakened response to flu vaccine
- Higher BMI in type 2 diabetes did not improve all-cause mortality risk
- Hypothyroidism not associated with mild cognitive impairment
- Increased testosterone testing found in men with normal hormone levels
- Look AHEAD: Intensive lifestyle intervention aided weight-loss management
- Lycopene-rich diet increased adiponectin, may protect against breast cancer
- New class of estrogen agents show promise in menopause treatment
-
- Pathways may identify targets for treating poorly differentiated, anaplastic thyroid cancer
- Tight glycemic control failed to benefit pediatric ICU patients
- USPSTF: Insufficient evidence on screening for gestational diabetes before 24 weeks
- Google developing smart contact lens for glucose monitoring in diabetes